NCT07267104 Mathematical Analysis of Signals and Clinical Parameters Provided by Non-invasive Home Ventilation Devices
| NCT ID | NCT07267104 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Corporacion Parc Tauli |
| Condition | COPD (Chronic Obstructive Pulmonary Disease) |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-03-25 |
| Primary Completion | 2025-04-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2025-03-25 with a primary completion date of 2025-04-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will look at people with COPD who use a home breathing machine called non-invasive ventilation (NIV). NIV machines collect information about your breathing, such as air flow, pressure, and mask leaks. Researchers want to use a computer program, called artificial intelligence (AI), to study this information. The goal is to find early signs that your breathing may be getting worse. People with COPD who already use NIV at home may join this study. The study does not change your treatment. It only uses the breathing data already recorded by your NIV machine. The computer program will look for patterns in the data. These patterns may help doctors: Notice early warning signs of a COPD flare-up Find problems with how you and the machine work together Improve the way NIV is monitored at home The main goal is to create a tool that helps patients and doctors manage home NIV more easily and more safely.
Eligibility Criteria
Inclusion Criteria: * Age between 40 and 80 years. * COPD diagnosed by pulmonary function tests. * Home NIV therapy with good adherence (minimum daily compliance \> 5 hours) for at least 6 months. * Users of the ResMed LUMIS 150 ventilator. This is due to the presence of the decoding tool and a larger storage capacity (more than 100 nights) in the removable device of the ventilator. * Acute exacerbation requiring hospital admission or home care. Exclusion Criteria: * Lack of informed consent. * Previous clinical instability defined by the need for antibiotics and/or systemic corticosteroids in the two months prior to the inclusion exacerbation, excluding the 48 hours prior to admission, as this was considered part of the inclusion clinical picture.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07267104 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying COPD (Chronic Obstructive Pulmonary Disease). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07267104 currently recruiting?
Yes, NCT07267104 is actively recruiting participants. Contact the research team at mlujan@tauli.cat for enrollment information.
Where is the NCT07267104 trial being conducted?
This trial is being conducted at Sabadell, Spain.
Who is sponsoring the NCT07267104 clinical trial?
NCT07267104 is sponsored by Corporacion Parc Tauli. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.